Fulgent Genetics Inc (FLGT)

Fulgent Genetics (FLGT) Stock Price & Analysis


FLGT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$23.09 - $44.09
Previous Close$27.61
Average Volume (3M)235.67K
Market Cap
Enterprise Value$749.60M
Total Cash (Recent Filing)$84.08M
Total Debt (Recent Filing)$2.89M
Price to Earnings (P/E)-12.9
Feb 29, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.14
Shares Outstanding29,633,057
10 Day Avg. Volume155,754
30 Day Avg. Volume235,667
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)0.85
Price to Sales (P/S)12.08
Price to Cash Flow (P/CF)20.20
P/FCF Ratio38.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.62
Enterprise Value/Gross Profit2.04
Enterprise Value/Ebitda-15.96
Price Target Upside1.41% Upside
Rating ConsensusHold
Number of Analyst Covering1



Ownership Overview

12.60% Mutual Funds
26.35% Other Institutional Investors
61.06% Public Companies and
Individual Investors


What was Fulgent Genetics Inc’s price range in the past 12 months?
Fulgent Genetics Inc lowest stock price was $23.09 and its highest was $44.09 in the past 12 months.
    What is Fulgent Genetics Inc’s market cap?
    Currently, no data Available
    When is Fulgent Genetics Inc’s upcoming earnings report date?
    Fulgent Genetics Inc’s upcoming earnings report date is Feb 29, 2024 which is in 93 days.
      How were Fulgent Genetics Inc’s earnings last quarter?
      Fulgent Genetics Inc released its earnings results on Nov 03, 2023. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of -$0.32 by -$0.07.
        Is Fulgent Genetics Inc overvalued?
        According to Wall Street analysts Fulgent Genetics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Fulgent Genetics Inc pay dividends?
          Fulgent Genetics Inc does not currently pay dividends.
          What is Fulgent Genetics Inc’s EPS estimate?
          Fulgent Genetics Inc’s EPS estimate is -$0.3.
            How many shares outstanding does Fulgent Genetics Inc have?
            Fulgent Genetics Inc has 29,633,057 shares outstanding.
              What happened to Fulgent Genetics Inc’s price movement after its last earnings report?
              Fulgent Genetics Inc reported an EPS of -$0.39 in its last earnings report, missing expectations of -$0.32. Following the earnings report the stock price went up 13.241%.
                Which hedge fund is a major shareholder of Fulgent Genetics Inc?
                Among the largest hedge funds holding Fulgent Genetics Inc’s share is Royce & Associates LLC. It holds Fulgent Genetics Inc’s shares valued at 718K.


                  Company Description

                  Fulgent Genetics Inc

                  Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.


                  Top 5 ETFs holding FLGT

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Vanguard Russell 3000 ETF
                  SPDR S&P 1500 Value Tilt ETF
                  BMO MSCI Innovation Index ETF
                  Up to five ETFs with an Outperform Smart Score that hold FLGT. The ETFs are listed according to market value of FLGT within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Guardant Health
                  Tandem Diabetes Care

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis